Related Experiment Video
Updated: Sep 22, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Mortality and causes of death in different celiac disease phenotypes during long-term follow-up
Inka Koskinen1, Kaisa Hervonen2, Heini Huhtala3
1Celiac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Department of Internal Medicine, Central Finland Central Hospital, Jyväskylä, Finland.
Insights
Long-term studies show overall mortality is not increased in celiac disease patients. However, risks for lymphoproliferative and central nervous system diseases are higher, while alcohol-related disease risk is lower.
Area of Science:
- Gastroenterology
- Epidemiology
- Clinical Medicine
Background:
- Celiac disease (CD) diagnosis has been linked to increased mortality, but comprehensive long-term data are limited.
- Understanding long-term survival trends is crucial for managing celiac disease patients effectively.
Purpose of the Study:
- To investigate the long-term overall and cause-specific mortality in a large cohort of celiac disease patients.
- To compare mortality risks in celiac disease patients against a matched general population.
Main Methods:
- A cohort of 1,392 celiac disease patients diagnosed between 1960-2000 was established.
- Patients were categorized by demographics and disease characteristics.
- Mortality data were collected over a median follow-up of 26.5 years and compared to 4,177 matched controls.
Main Results:
- Over 41 years, all-cause mortality was not significantly increased in celiac disease patients (HR 0.96).
- Increased mortality was observed for lymphoproliferative diseases (HR 2.42) and central nervous system diseases (HR 2.14).
- A decreased risk was noted for alcohol-related diseases (HR 0.31).
Conclusions:
- Overall mortality in celiac disease patients is not elevated, even with extended follow-up.
- Specific causes of death, including certain cancers and neurological conditions, warrant continued monitoring in celiac disease management.
- No significant mortality differences were found across various celiac disease phenotypes.
Background:
Celiac disease has been associated with increased mortality, but data on long-term mortality are scarce.
Aims:
To determine long-term mortality in celiac disease.
Methods:
The study cohort consisted of all celiac disease patients (n=1,392) diagnosed in Tampere University Hospital catchment area 1960 - 2000. Patients were categorized into subgroups based on demographic (age, gender, decade of diagnosis) and celiac disease characteristics (e.g., phenotype, severity of villous atrophy) collected from medical records. Overall and cause-specific mortality was compared to those of age-, sex-, and place of residence matched reference individuals (n=4,177) over time.
Results:
During the 41 years of follow-up (median 26.5 years), 376 celiac disease patients and 1,155 reference individuals died. All-cause mortality was not increased (hazard ratio (HR) 0.96, 95% confidence intervals (CI) 0.85-1.08). Mortality from lymphoproliferative diseases and diseases of the central nervous system was increased (HR 2.42, 95% CI 1.38-4.24 and HR 2.14, 95% CI 1.05-4.36 respectively) while the risk from alcohol related diseases was decreased (HR 0.31, 95% CI 0.09-1.00). Examination of various celiac disease phenotypes revealed no significant differences in mortality CONCLUSIONS: Overall mortality was not increased in any celiac disease phenotype during a very long-term follow-up.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Related Concept Videos
Longitudinal Research
Assumptions of Survival Analysis
Cancer Survival Analysis
Life Tables
Chronic Kidney Disease II: Clinical Manifestations
Chronic Pancreatitis II: Collaborative Care
Assessment: